| First Author | Song J | Year | 2021 |
| Journal | EMBO Rep | Volume | 22 |
| Issue | 2 | Pages | e51162 |
| PubMed ID | 33393230 | Mgi Jnum | J:306298 |
| Mgi Id | MGI:6712145 | Doi | 10.15252/embr.202051162 |
| Citation | Song J, et al. (2021) The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep 22(2):e51162 |
| abstractText | Although iron is required for cell proliferation, iron-dependent programmed cell death serves as a critical barrier to tumor growth and metastasis. Emerging evidence suggests that iron-mediated lipid oxidation also facilitates immune eradication of cancer. However, the regulatory mechanisms of iron metabolism in cancer remain unclear. Here we identify OTUD1 as the deubiquitinase of iron-responsive element-binding protein 2 (IREB2), selectively reduced in colorectal cancer. Clinically, downregulation of OTUD1 is highly correlated with poor outcome of cancer. Mechanistically, OTUD1 promotes transferrin receptor protein 1 (TFRC)-mediated iron transportation through deubiquitinating and stabilizing IREB2, leading to increased ROS generation and ferroptosis. Moreover, the presence of OTUD1 promotes the release of damage-associated molecular patterns (DAMPs), which in turn recruits the leukocytes and strengthens host immune response. Reciprocally, depletion of OTUD1 limits tumor-reactive T-cell accumulation and exacerbates colon cancer progression. Our data demonstrate that OTUD1 plays a stimulatory role in iron transportation and highlight the importance of OTUD1-IREB2-TFRC signaling axis in host antitumor immunity. |
